{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:33:12Z","timestamp":1793046792646,"version":"4.5.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":243,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002918","name":"Gentofte Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002918","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003491","name":"Herlev Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.lrr.2026.100604","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T06:53:55Z","timestamp":1788332035000},"page":"100604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Unusually long remission in two patients with follicular lymphoma receiving immunomodulating therapeutic cancer vaccines"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3764-8578","authenticated-orcid":false,"given":"Morten Orebo","family":"Holmstr\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamaila Munir","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uffe","family":"Klausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0264-6388","authenticated-orcid":false,"given":"Mads Emil","family":"Bj\u00f8rn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Ortved","family":"Gang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarec Christoffer","family":"El-Galaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9419-8841","authenticated-orcid":false,"given":"Lars M\u00f8ller","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2914-9605","authenticated-orcid":false,"given":"Mads Hald","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lrr.2026.100604_bib0001","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1200\/JCO.18.02365","article-title":"Progression of disease within 24 months in follicular lymphoma is associated with reduced intratumoral immune infiltration","volume":"37","author":"Tobin","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lrr.2026.100604_bib0002","article-title":"The inhibitory checkpoint, PD-L2, is a target for effector T cells: novel possibilities for immune therapy","volume":"7","author":"Ahmad","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.lrr.2026.100604_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2026.04.010","article-title":"IO102-IO103 immune-modulatory cancer vaccine and pembrolizumab in melanoma","author":"Hassel","year":"2026","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lrr.2026.100604_bib0004","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1975889","article-title":"An immunogenic first-in-human immune modulatory vaccine with PD-L1 and PD-L2 peptides is feasible and shows early signs of efficacy in follicular lymphoma","volume":"10","author":"Klausen","year":"2021","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.lrr.2026.100604_bib0005","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa041869","article-title":"Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells","volume":"351","author":"Dave","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lrr.2026.100604_bib0006","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1182\/blood-2005-04-1565","article-title":"Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL)","volume":"106","author":"Farinha","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2026.100604_bib0007","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3324\/haematol.2017.165415","article-title":"Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg lymphoma biomarker consortium","volume":"102","author":"Stevens","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.lrr.2026.100604_bib0008","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1182\/blood-2015-04-640912","article-title":"DC-SIGN\u2013expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma","volume":"126","author":"Amin","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2026.100604_bib0009","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/bjh.18881","article-title":"Long-term follow-up confirms the favourable prognostic impact of high numbers of tumour infiltrating <scp>CD3<\/scp>T-cells in follicular lymphoma patients treated by rituximab-maintenance regimen","volume":"202","author":"Laurent","year":"2023","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.lrr.2026.100604_bib0010","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41392-026-02710-8","article-title":"Immune modulatory vaccines targeting tumor microenvironment antigens: recent advances in oncology and beyond","volume":"11","author":"Andersen","year":"2026","journal-title":"Signal Transduct. Target. Ther."}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048926000440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048926000440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:33:42Z","timestamp":1793043222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048926000440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":10,"alternative-id":["S2213048926000440"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2026.100604","relation":{},"ISSN":["2213-0489"],"issn-type":[{"value":"2213-0489","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unusually long remission in two patients with follicular lymphoma receiving immunomodulating therapeutic cancer vaccines","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2026.100604","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100604"}}